Advertisement
CLPBF vs ESLOY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBF is a Hold and ESLOY is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLPBF’s FA Score shows that 1 FA rating(s) are green whileESLOY’s FA Score has 2 green FA rating(s).
- CLPBF’s FA Score: 1 green, 4 red.
- ESLOY’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLPBF’s TA Score shows that 3 TA indicator(s) are bullish while ESLOY’s TA Score has 4 bullish TA indicator(s).
- CLPBF’s TA Score: 3 bullish, 4 bearish.
- ESLOY’s TA Score: 4 bullish, 4 bearish.
Price Growth
CLPBF (@Pharmaceuticals: Other) experienced а -5.27% price change this week, while ESLOY (@Pharmaceuticals: Other) price change was -1.92% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.63%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was +1.00%.
Reported Earning Dates
ESLOY is expected to report earnings on Mar 06, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-0.63% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| CLPBF | ESLOY | CLPBF / ESLOY | |
| Capitalization | 19.3B | 148B | 13% |
| EBITDA | 8.36B | 6.71B | 125% |
| Gain YTD | -22.701 | 35.822 | -63% |
| P/E Ratio | 32.87 | 52.22 | 63% |
| Revenue | 27.9B | 27.2B | 103% |
| Total Cash | 947M | 3.16B | 30% |
| Total Debt | 22.6B | 14B | 161% |
CLPBF | ESLOY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 92 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 16 | |
SMR RATING 1..100 | 43 | 95 | |
PRICE GROWTH RATING 1..100 | 77 | 53 | |
P/E GROWTH RATING 1..100 | 56 | 33 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CLPBF's Valuation (9) in the null industry is in the same range as ESLOY (34). This means that CLPBF’s stock grew similarly to ESLOY’s over the last 12 months.
ESLOY's Profit vs Risk Rating (16) in the null industry is significantly better than the same rating for CLPBF (100). This means that ESLOY’s stock grew significantly faster than CLPBF’s over the last 12 months.
CLPBF's SMR Rating (43) in the null industry is somewhat better than the same rating for ESLOY (95). This means that CLPBF’s stock grew somewhat faster than ESLOY’s over the last 12 months.
ESLOY's Price Growth Rating (53) in the null industry is in the same range as CLPBF (77). This means that ESLOY’s stock grew similarly to CLPBF’s over the last 12 months.
ESLOY's P/E Growth Rating (33) in the null industry is in the same range as CLPBF (56). This means that ESLOY’s stock grew similarly to CLPBF’s over the last 12 months.
| CLPBF | ESLOY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 39% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 64% | N/A |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 2 days ago 52% | 2 days ago 48% |
| TrendMonth ODDS (%) | 2 days ago 50% | 2 days ago 47% |
| Advances ODDS (%) | N/A | 23 days ago 57% |
| Declines ODDS (%) | N/A | 2 days ago 50% |
| BollingerBands ODDS (%) | 2 days ago 55% | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 48% | 2 days ago 36% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MEDX | 33.54 | 0.20 | +0.59% |
| Horizon Kinetics Medical ETF | |||
| EZA | 69.92 | 0.38 | +0.55% |
| iShares MSCI South Africa ETF | |||
| FTCS | 93.65 | 0.40 | +0.43% |
| First Trust Capital Strength ETF | |||
| RFDI | 80.78 | 0.14 | +0.17% |
| First Trust RiverFront Dyn Dev Intl ETF | |||
| SOUX | 15.78 | -0.25 | -1.55% |
| Defiance Daily Target 2X Long SOUN ETF | |||
CLPBF and
Correlation & Price change
A.I.dvisor indicates that over the last year, CLPBF has been loosely correlated with CLPBY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBF jumps, then CLPBY could also see price increases.
| Ticker / NAME | Correlation To CLPBF | 1D Price Change % | ||
|---|---|---|---|---|
| CLPBF | 100% | -2.13% | ||
| CLPBY - CLPBF | 38% Loosely correlated | -0.12% | ||
| AHICF - CLPBF | 26% Poorly correlated | N/A | ||
| WILLF - CLPBF | 22% Poorly correlated | N/A | ||
| QDEL - CLPBF | 20% Poorly correlated | +1.12% | ||
| ESLOY - CLPBF | 20% Poorly correlated | -0.43% | ||
More | ||||
ESLOY and
Correlation & Price change
A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.
| Ticker / NAME | Correlation To ESLOY | 1D Price Change % | ||
|---|---|---|---|---|
| ESLOY | 100% | -0.43% | ||
| ESLOF - ESLOY | 58% Loosely correlated | +1.53% | ||
| QGEN - ESLOY | 43% Loosely correlated | -0.29% | ||
| ALC - ESLOY | 38% Loosely correlated | +0.06% | ||
| SMMNY - ESLOY | 38% Loosely correlated | N/A | ||
| CRL - ESLOY | 35% Loosely correlated | +0.14% | ||
More | ||||